Caveolin-1 expression in ovarian carcinoma is MDR1 independent

American Journal of Clinical Pathology

Volumn 117, Issue 2, 2002, Pages 225-234

  Davidson, Ben ^a   Goldberg, Iris ^a   Givant Horwitz, Vered ^a   Nesland, Jahn M ^a   Berner, Aasmund ^a   Bryne, Magne ^a   Risberg, Bjørn ^a   Kopolovic, Juri ^a   Kristensen, Gunnar B ^a   Tropé, Claes G ^a   Van de Putte, Gregg ^a   Reich, Reuven ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Caveolin; Immunohistochemistry; MRNA in situ hybridization; Multidrug resistance; Reverse transcription polymerase chain reaction; Serous effusions

Indexed keywords

CAVEOLIN 1; GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CELL MEMBRANE; CELL METABOLISM; CONTROLLED STUDY; DIAGNOSTIC TEST; EFFUSION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH;

ADULT; AGED; ASCITIC FLUID; CARCINOMA; CAVEOLIN 1; CAVEOLINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MIDDLE AGED; NEOPLASM, RESIDUAL; OVARIAN NEOPLASMS; P-GLYCOPROTEIN; PERITONEAL NEOPLASMS; PLEURAL EFFUSION, MALIGNANT; PLEURAL NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 0036328948     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/U40R-1BN4-6KJ3-BDG3     Document Type: Article

References (42)

1. Caveolin, a protein component of caveolae membrane coats
2. Caveolae: Where incoming and outgoing messengers meet
3. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane
4. Protein complexes '98: Molecular genetics of the caveolin gene family: Implications for human cancers, diabetes, Alzheimer disease, and molecular dystrophy
5. Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers
6. Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1): Methylation of a CpG island in the 5′ promoter region of the caveolin-1 gene in human breast cancer cell lines
7. Reduction of caveolin 1 gene expression in lung carcinoma cell lines
8. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins: Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities
9. Caveolin is an inhibitor of platelet-derived growth factor receptor signaling
10. Reciprocal regulation of Neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo: Implications for human breast cancer
11. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-dependent growth
12. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells
13. Analysis of caveolin-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines
14. Elevated expression of caveolin is associated with prostate and breast cancer
15. Caveolin-1 expression in clinically confined human prostate cancer: A novel prognostic marker
16. Downregulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression
17. P-glycoprotein in adult solid tumors: Expression and prognostic significance
18. Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance
19. Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas
20. Multidrug resistance in ovarian cancer
21. Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas
22. Expression of a human multidrug resistance gene in ovarian carcinomas
23. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells
24. Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells
25. Global cancer statistics
26. Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993
27. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: Evidence of up-regulated Tn and sialyl Tn antigens expression in effusions
28. Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels
29. E-cadherin and alpha-, beta- and gamma-catenin protein expression is upregulated in ovarian carcinoma cells in serous effusions
30. Up-regulation of CD44s, but not of CD44v3-10, in ovarian carcinoma cells in malignant effusions
31. Detection of cancer cells in effusions from patients diagnosed with gynecological malignancies: Evaluation of five epithelial markers
32. Surface epithelialstromal tumors of the ovary
33. Expression of metastasis-related genes in surgical specimens of human gastric cancer can predict disease recurrence
34. Complete one-hour immunocytochemistry based on capillary action
35. High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma
36. Interleukin-8 and vascular endothelial growth factor mRNA levels are down-regulated in ovarian carcinoma cells in serous effusions
37. A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling
38. beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro
39. Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: Identification of a c-Src/Cav-1/Grb7 signaling cassette
40. Tyrosine-phosphorylated caveolin-1: Immunolocalization and molecular characterization
41. Caveolin-1 expression in advanced-stage ovarian carcinoma: Clinicopathologic study